SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

10066	Companies
205763	Keywords
136024	Articles
109099	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 10/24/2024 at 14:00, 1 year 4 months ago

Communiqué de presse : Dupixent : Présentation de nouvelles données positives de phase III dans le traitement de l’urticaire chronique spontanée au Congrès de l’ACAAI
Dupixent : Présentation de nouvelles données positives de phase III dans le traitement de l’urticaire chronique spontanée au Congrès de l’ACAAI. Les résultats du Dupixent montrent une réduction significative du prurit et de l'activité de l’urticaire

Traitement Dupixent Phase III Urticaire Chronique Spontanée ACAAI
BRIEF

published on 10/21/2024 at 07:35, 1 year 5 months ago

Sanofi et CD&R unissent leurs forces pour faire croître Opella

Transaction Financière Sanofi CD&R Opella Santé Grand Public
BRIEF

published on 10/21/2024 at 07:35, 1 year 5 months ago

Sanofi and CD&R join forces to grow Opella

Financial Transaction Sanofi CD&R Opella Consumer Health
PRESS RELEASE

published on 10/21/2024 at 07:30, 1 year 5 months ago

Communiqué de presse : Sanofi et CD&R s’allient pour soutenir les ambitions d’Opella dans la santé grand public
Sanofi et CD&R s'allient pour soutenir Opella dans la santé grand public. Opella devient un leader indépendant avec le soutien de Sanofi. CD&R apporte son expérience pour accélérer la croissance

Croissance Sanofi CD&R Opella Santé Grand Public
PRESS RELEASE

published on 10/21/2024 at 07:30, 1 year 5 months ago

Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare
Sanofi and CD&R partner to fuel Opella's ambitions in consumer healthcare as Sanofi transfers a 50% stake in Opella. Opella to become a standalone leader backed by Sanofi's strategic support and guidance

Partnership Sanofi CD&R Consumer Healthcare Opella
BRIEF

published on 10/15/2024 at 22:10, 1 year 5 months ago

Sanofi Reports Share and Voting Rights Data for September 2024

Voting Rights Investor Information Sanofi September 2024 Shares Data
BRIEF

published on 10/15/2024 at 22:10, 1 year 5 months ago

Sanofi publie ses données sur les actions et les droits de vote pour septembre 2024

Droit De Vote Sanofi Informations Pour Les Investisseurs Septembre 2024 Partage Des Données
PRESS RELEASE

published on 10/15/2024 at 22:05, 1 year 5 months ago

Sanofi: Information concerning the total number of voting rights and shares - September 2024
Sanofi reports total number of voting rights and shares as of September 30, 2024, in compliance with French commercial and stock market regulations

Voting Rights French Commercial Code Shares Sanofi Stock Market Authority
PRESS RELEASE

published on 10/15/2024 at 22:05, 1 year 5 months ago

Sanofi: Informations relatives au nombre de droits de vote et d'actions - SEPTEMBRE 2024
Sanofi communique sur le nombre total de droits de vote et d'actions conformément aux réglementations en vigueur

Autorité Des Marchés Financiers Droits De Vote Actions Règlement Général Sanofi
BRIEF

published on 10/11/2024 at 08:35, 1 year 5 months ago

Sanofi envisage de céder une part majoritaire d'Opella

Participations Santé Sanofi CD&R Opella

Accesswire

Published on 03/23/2026 at 14:05, 1 hour 1 minute ago

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 1 hour 6 minutes ago

BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 2 hours 1 minute ago

SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 2 hours 34 minutes ago

Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 2 hours 36 minutes ago

Digi Power X to Announce 2025 Year End Financial Results on March 31st

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 14:41, 24 minutes ago

CEWE increases dividend for 17 consecutive years
Published on 03/23/2026 at 14:30, 36 minutes ago

Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
Published on 03/23/2026 at 14:30, 36 minutes ago

Belvilla Expands in Germany with Hambachtal Holiday Park in Oberhambach
Published on 03/23/2026 at 14:24, 42 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 03/23/2026 at 14:22, 44 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior plc

Les Echos

Published on 03/23/2026 at 08:10, 6 hours 56 minutes ago

Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 20 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 20 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 20 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 20 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA

View all LES ECHOS COMFI WIRE